Hitachi Recalls PROBEAT-CR Proton Beam Therapy System Due to Software Anomaly
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Hitachi, Ltd. has issued a voluntary recall for a PROBEAT-CR Proton Beam Therapy unit due to a software defect that may cause patient positioning discrepancies.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references Texas and Washington D.C.. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Hitachi, Ltd. Radiation Oncology Systems, Kashiwanoha, has initiated a voluntary recall of its PROBEAT-CR Proton Beam Therapy system. The recall was triggered by the identification of a software anomaly within the patient positioning system. This defect may result in a positional discrepancy during treatment, potentially affecting the accuracy of the therapy delivery.
Which Products Are Affected
The recall specifically affects one unit of the following medical device:
- Brand Name: Hitachi Proton Beam Therapy
- Model/REF: PROBEAT-CR
- Serial Number: CRUS01
- UDI: (01)04560333350006(21)CRUS01(11)190920
- Recall Number: Z-1430-2026
Distribution of the affected unit was limited to facilities in Texas and Washington D.C.
What You Should Do
The firm initiated the recall process through direct visits to the affected sites. Healthcare facilities and operators using the PROBEAT-CR system with the specified serial number should ensure they have coordinated with Hitachi, Ltd. representatives regarding the software anomaly and any necessary technical corrections.
Why This Matters
In radiation oncology, precise patient positioning is vital for ensuring that therapy is targeted correctly. A software-driven positional discrepancy could lead to radiation being delivered to unintended areas, which poses a risk to patient safety and treatment effectiveness.
Source
Data provided by the FDA under Recall Number Z-1430-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.